Investment Q&A

Q: First of all, I can't thank you enough for the excellence of your answers. I have been a member for many years. The answers just keep getting better.
Re my question:
I keep having to trim my tech sector. Perhaps I should sell a couple of names instead of just trimming? Would you please arrange these best to last? Many thanks.

Q: Would you be aware of any plans for a Nasdaq listing for KXS? Currently, there appears to be a listing on the 'pink sheets' only with minor trading volume.
I would also appreciate your assessment of the stock and its current growth potential.
Thank you, Team!

Q: There are apparently class-action suits being launched against Revera and Sienna relating to covid deaths in their homes. Before long this may well involve Extendicare and Chartwell at a guess. How meaningful to a company's future would you expect these suits could be? Are there any legal precedents (re: alleged lack of proper patient/resident care) involving senior homes in Canada? I have held both Chartwell and Sienna for years, and done well with them up until all this. I have reduced both by about half, but do you think it is just better to exit this sector for now?
Thank-you

Q: I'm looking at buying gold bullion etf and try to decide between CGL.C and PHYS which has a slightly lower expense ratio. What's the plus and minus for each of these ETFs and what will be your preference and why? Thanks for sharing your insight.

Q: I currently own these tech stocks: GOOG, CSU, SHOP, KXS, LSPD, OTEX, and GIB.A. I want to consolidate and simplify my holdings based on balance sheet and growth projection thru this pandemic. I'm thinking of selling two out of this list and am leaning towards selling either, LSPD, OTEX or GIB.A. Which two would you pick and the reasons behind? Thanks so much.

Q: Hello to the team
How reliable are the divi. on this companies there are an integral part of my retirement,generally they are less 10 years in the market and being clobbered,should' i reduce some of these position and replace them with some exposure to US. like PDI or wait as long that the divi is there,i'm 76.
Thank You

Q: What’s your thoughts on Uber and Grubhub as companies as well as the potential acquisition of Grubhub by Uber?

Thnx again!!!
Dave

Q: Hello 5i team. I read with interest how contrary to steelmakers worldwide who are battening down the hatches, Stelco CEO Alan Kestenbaum is betting big on a renaissance in North American manufacturing and construction by making $110-million of investments with the goal of turning Stelco into North America's most efficient steel maker. Ballsy. I agree with him that the other side of this panedemic will see an onshoring of manufacturing capacity in North America. The biggest risk I see with this one is if Trump ever decided to re-impose the steel tariffs. At just over $6/share, do you see this stock as a buy for a semi-patient investor with a long time horizon? Also, how sustainable is the dividend?

Q: With hexo’s debenture conversion and their subsequent equity issue, do they have much debt outstanding?

Q: Hi Team,

Can I have your views on ACB recent earnings report? Do you see a turnaround for the company? Is it worth starting a small position?
Thanks

Kuldip

Q: Can you please provide an update on this company. It is vastly underperforming the tech sector recovery. I keep averaging down my cost base.
What is your outlook for the company?
Is it worth holding. Do you hold it yourself ?
Thank you z

Q: WHAT DO YOU SEE AS THE POTENTIAL FOR THIS STOCK?

Q: Hi 5i Team
I hold these 3 REITS and would like to consolidate to one. Which would you advise to hold for long term considering recovery and dividend security?
Thanks

Q: Hi : What's your view on Monster Beverage? It screens well (based on pre-CoVid data) but I am unsure how its business will be affected by the CoVid situation. Are there other companies in the same space that you like better?

Thanks for your insight,

JohnR

Q: “Management teams prioritized liquidity and balance sheet strength,” Goldman said in a report to clients published earlier this week. “Heightened uncertainty prompted companies to reduce capital expenditures, buybacks, and dividends.”

Given this statement what do you consider the main focus areas for analyzing a company? PE? Book value? Free cash flow? Payout ratio? Debt/Equity? Revenue changes?

Thanks.

Q: Your top 5 consumer stocks for long-term hold? US would be ok.

Q: According to Reuters article, companies exercising ESG management are getting favourable attention from large investors. I expect some companies will attract a premium price for some time if they demonstrate ESG and advertise the fact. Could you list a half dozen of 5I favourites companies which are at least on the ESG narrow path to higher valuations.
Thank You for your service.

Q: There was an announcement a couple of days ago that BC Hydro was idling some facilities due to a reduction in demand. In the current situation I would guess that there must be a significant reduction in the industrial use of electricity. The prices of AQN and FTS have pulled back a bit. NPI is up today, perhaps on decent results. What does your crystal ball tell you about the demand for electricity going forward and the future prices of utility stocks.
Thanks for your thoughts.
Ian

Q: San Diego small cap Sorrento Therapeutics stock exploded on Friday. Sorrento said it's STI-1499 antibody demonstrated 100% inhibition of the COVID-19 virus infection of healthy cells in pre-clinical trials. The company advised full results of the experiment will soon be submitted to a "peer-reviewed publication." A week ago they announced an agreement to work with Mount Sinai Health System on a phase one clinical trial of the retained plasma of 15000 covid patients commencing in Q3.
The company appears to be claiming that STI-1499 at the pre-clinical stage is a cure which they plan to develop as a stand alone treatment as well as the 1st part of an antibody cocktail treatment which they are developing in cooperation with Mount Sinai for the same purpose.
Generally speaking I am an investor, not a gambler but am interested in your views/comments on this company and it's financial situation, which is why I mention the word "gamble". Would you invest/gamble ? on this co. at this stage or sit back and wait for further confirmation of test results.

John

Q: So with an imminent financial challenge ahead why would one buy any financials or keep them for that matter? I know the Canadian bank dividends are mostly rock solid but how can there be much growth with foreclosures and debt issues in the foreseeable future. After the current health situation subsides hopefully in a couple of years, one could go back into the banks to regain the diversification and dividends. Thanks for your valued insight.
Dennis